StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$157.72−4.84 (-2.98%)

Close on Nov 17, 2026Market cap $6.20BP/E –Yield –

Belite Bio total assets

Total assets on the balance sheet at the end of each period.

Belite Bio's total assets was $780.56M at Dec 31, 2025. For fiscal 2025 it was $780.56M, up 413.1% from the year before. The highest annual figure on record is $780.56M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$780.56M+413.1%
FY2024Dec 31, 2024$152.13M+60.7%
FY2023Dec 31, 2023$94.64M+113.8%
FY2022Dec 31, 2022$44.27M+141.3%
FY2021Dec 31, 2021$18.35M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$780.56M+4154.2%
Q4 FY2024Dec 31, 2024$152.13M–
Q4 FY2023Dec 31, 2023$94.64M–
Q4 FY2022Dec 31, 2022$44.27M–
Q4 FY2021Dec 31, 2021$18.35M–

More Belite Bio figures

See a number that looks wrong?